Vicore Pharma Holding AB VCRE · SEC Filings

website

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with...

Price11.27

Market Cap317.41 M

Float28.14 M

CountrySE

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

6-K

Vicore Pharma Announces Third Quarter 2026 Financial Results and Business Update

Nov 5, 2026

6-K

Vicore Announces Nomination Committee for the 2027 Annual General Meeting

Nov 3, 2026

6-K

Vicore’s Phase 2b ASPIRE Trial of Buloxibutid in IPF Passes Pre-Planned Futility Analysis and Remains on Track for Mid-2027 Topline Results

Oct 22, 2026

6-K

Vicore Pharma Announces Increase in Shares and Votes Following Incentive Program Exercise

Sep 30, 2026

6-K

Vicore Pharma Holding AB Q2 2026 Interim Report and U.S. Market Listing

Aug 21, 2026

6-K

Vicore Pharma Appoints Rob Slack as Chief Scientific Officer

Jul 6, 2026

Prospectus

TYPE

HEADLINE

FILED AT

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 21, 2026

20FR12B/A

Form 20FR12B/A - Registration of securities [Section 12(b)]: [Amend]

Jun 9, 2026

20FR12B

Form 20FR12B - Registration of securities [Section 12(b)]

May 22, 2026

DRS

Form DRS - Draft Registration Statement

Apr 17, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

HBM Healthcare Investments (Cayman) Ltd. (Filed by)

Oct 13, 2026

Other

TYPE

HEADLINE

FILED AT

ORDER

Form SEC STAFF ACTION - SEC Staff Action: ORDER

Jun 30, 2026